COST-EFFECTIVENESS OF FINGOLIMOD, TERIFLUNOMIDE, DIMETHYL FUMARATE AND INTRAMUSCULAR INTERFERON BETA-1A IN RELAPSING-REMITTING MULTIPLE SCLEROSIS

被引：3
|
作者：
Zhang, X. [1 ]
Hay, J. W. [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.351
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND20
引用
收藏
页码：A59 / A60
页数：2
相关论文
共 50 条
  • [21] Cost-Effectiveness of Fingolimod in Treating Patients With Relapsing-Remitting Multiple Sclerosis
    Agashivala, Neetu V.
    Dastani, Homa B.
    Carlton, Rashad
    Sarnes, Evelyn
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2011, 3 (06) : 320 - 328
  • [22] COST-EFFECTIVENESS ANALYSIS OF ALEMTUZUMAB IN COMPARISON WITH NATALIZUMAB, INTRAMUSCULAR INTERFERON BETA-1A, SUBCUTANEOUS INTERFERON BETA-1B, AND FINGOLIMOD FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN IRAN
    Taheri, S.
    Yousefi, N.
    Sahraian, M. A.
    Mehralian, G.
    VALUE IN HEALTH, 2017, 20 (09) : A723 - A723
  • [23] The Impact of Price Reductions After Loss of Exclusivity in a Cost-Effectiveness Analysis: Fingolimod Versus Interferon Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
    Hua, Le H.
    Hersh, Carrie M.
    Morten, Peter
    Kusel, Jeanette
    Lin, Feng
    Cave, Julie
    Varga, Stefan
    Herrera, Vivian
    Ko, John J.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (04): : 490 - +
  • [24] Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis
    Lorscheider, Johannes
    Benkert, Pascal
    Lienert, Carmen
    Haenni, Peter
    Derfuss, Tobias
    Kuhle, Jens
    Kappos, Ludwig
    Yaldizli, Oezguer
    JOURNAL OF NEUROLOGY, 2021, 268 (03) : 941 - 949
  • [25] COST-EFFECTIVENESS OF DACLIZUMAB VERSUS INTERFERON BETA-1A IN THE TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN THE UNITED STATES
    Rao, D.
    Heidari, E.
    Kamal, K. M.
    Dashputre, A. A.
    VALUE IN HEALTH, 2018, 21 : S206 - S206
  • [26] Effect of Intramuscular Interferon beta-1a on Gray Matter Atrophy in Relapsing-Remitting Multiple Sclerosis
    Nakamura, Kunio
    Rudick, Richard
    Lee, Jar-Chi
    Foulds, Pamela
    Fisher, Elizabeth
    NEUROLOGY, 2010, 74 (09) : A407 - A407
  • [27] The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis
    Dupuy, Sheena L.
    Khalid, Fariha
    Healy, Brian C.
    Bakshi, Sonya
    Neema, Mohit
    Tauhid, Shahamat
    Bakshi, Rohit
    BMC MEDICAL IMAGING, 2016, 16
  • [28] The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis
    Dupuy, S.
    Khalid, F.
    Healy, B. C.
    Bakshi, S.
    Neema, M.
    Tauhid, S.
    Bakshi, R.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 232 - 232
  • [29] The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis
    Sheena L. Dupuy
    Fariha Khalid
    Brian C. Healy
    Sonya Bakshi
    Mohit Neema
    Shahamat Tauhid
    Rohit Bakshi
    BMC Medical Imaging, 16
  • [30] Cost-effectiveness analysis of peginterferon beta-1a compared with interferon beta-1a and glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis in the United States
    Hernandez, Luis
    Guo, Shien
    Kinter, Elizabeth
    Fay, Monica
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (07) : 684 - 695
12345